Cargando…
Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
OBJECTIVE: Ashkenazi‐Jewish (AJ) population‐based BRCA testing is acceptable, cost‐effective and amplifies primary prevention for breast & ovarian cancer. However, data describing lifestyle impact are lacking. We report long‐term results of population‐based BRCA testing on lifestyle behaviour an...
Autores principales: | Burnell, Matthew, Gaba, Faiza, Sobocan, Monika, Desai, Rakshit, Sanderson, Saskia, Loggenberg, Kelly, Gessler, Sue, Side, Lucy, Brady, Angela F., Dorkins, Huw, Wallis, Yvonne, Jacobs, Chris, Legood, Rosa, Beller, Uziel, Tomlinson, Ian, Wardle, Jane, Menon, Usha, Jacobs, Ian, Manchanda, Ranjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796935/ https://www.ncbi.nlm.nih.gov/pubmed/35781768 http://dx.doi.org/10.1111/1471-0528.17253 |
Ejemplares similares
-
Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014) -
Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial
por: Manchanda, Ranjit, et al.
Publicado: (2014) -
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
por: Khankhanian, Pouya, et al.
Publicado: (2015) -
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping
por: Olshen, Adam B, et al.
Publicado: (2008) -
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews
por: Gaba, Faiza, et al.
Publicado: (2022)